Advaxis’ Immunotherapy in Combination with Chemoradiation Highlighted as Potential Treatment for Anal Cancer in … – Business Wire (press release)
|
Advaxis' Immunotherapy in Combination with Chemoradiation Highlighted as Potential Treatment for Anal Cancer in …
Business Wire (press release) PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announces that data from the investigator-initiated study … |
